Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)- positive and HIV-negative immunocompromised patients

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1519-1523

  Nüesch, Reto ^a   Bellini, Cristina ^a   Zimmerli, Werner ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LENGTH OF STAY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; VIRUS PATHOGENESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE FACTORS; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBINS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; SURVIVAL RATE; SWEATING; WEIGHT LOSS;

EID: 0033384645     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313534     Document Type: Article

References (31)

1. 1. Dutz W. Pneumocystis carinii pneumonia. Pathol Annu 1970; 5:309-41.
2. 2. Burke B, Good R. Pneumocystis carinii infection. Medicine 1973; 52:23-51.
3. 3. Walzer P, Perl D, Krogstad D, Schultz M. Pneumocystis carinii pneumonia in the United States: epidemiologic, clinical and diagnostic features. Ann Intern Med 1974; 80:83-93.
4. 4. Bachelez H, Schremmer B, Cadranel J, et al. Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis. Arch Intern Med 1997; 157:1501-3.
5. 5. Varela JM, Fernandez-Alonso J, Wichmann I, Calderon EJ. Pneumocystis carinii investigation in patients with Wegener's granulomatosis. Br J Rheumatol 1998; 37:349-50.
6. 6. Lufft V, Kliem V, Behrend M, Pichlmayr R, Koch KM, Brunkhorst R. Incidence of Pneumocystis carinii pneumonia after renal transplantation: impact of immunosuppression. Transplantation 1996; 62:421-3.
7. 7. Kulke M, Vance E. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin Infect Dis 1997; 25:215-8.
8. 8. Arend SM, Kroon FP, Van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. Arch Intern Med 1995; 155: 2436-41.
9. 9. Sepkowitz K. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 1993; 17(Suppl 2):S416-22.
10. 10. Varthalitis I, Aoun M, Dabneau D, Meunier F. Pneumocystis carinii pneumonia in patients with cancer. Cancer 1993; 71:481-5.
11. 11. Smith MB, Hanauer SB. Pneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis. N Engl J Med 1992; 327:497-8.
12. + T-lymphocytopenia: an analysis of five patients with unexplained opportunistic infections. N Engl J Med 1993; 328:386-92.
13. 13. Ewig S, Bauer T, Schneider C, et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J 1995; 8:1548-53.
14. 14. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100:663-71.
15. 15. Sterling R, Bradley B, Khalil K, Kerman R, Conklin R. Comparison of biopsy-proven Pneumocystis carinii pneumonia in acquired immune deficiency syndrome patients and renal allograft recipients. Ann Thorac Surg 1984; 38:494-9.
16. 16. Furio M, Weidle P, Wordell C, Liu H. Management of Pneumocystis carinii pneumonia in patients with AIDS and other conditions: experience in a Philadelphia university teaching hospital. Pharmacotherapy 1988; 8: 221-34.
17. 17. Montaner J, Lawson L, Gerwais A, et al. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomized, placebo-controlled study. Ann Intern Med 1991; 114:948-53.
18. 18. Hirschel B, Lazzarin A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991; 324:1079-83.
19. 19. Leoung GS, Feigal DW, Montgomery AB, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii: the San Francisco Community Prophylaxis Trial. N Engl J Med 1990; 323:769-75.
20. 20. Bucher HC, Griffith L, Guyatt GH, Opravil M. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:104-14.
21. 21. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicenter study. BMJ 1997; 315:1194-9.
22. 22. Limper AH, Offord KP, Smith TF, Martin WJ. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140:1204-9.
23. 23. Stover D, Zaman M, Hajdu S, Lange M, Gold J, Armstrong D. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med 1984; 101:1-7.
24. 24. Broaddus C, Dake M, Stulbarg M, et al. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102:747-52.
25. 25. Fleury-Feith J, Van Nhieu JT, Picard C, Escudier E, Bernaudin JF. Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients. Chest 1989, 95:1198-201.
26. 26. Nathan SD, Ross DJ, Zakowski P, Kass RM, Koerner SK. Utility of inhaled pentamidine prophylaxis in lung transplant recipients. Chest 1994; 105: 417-20.
27. 27. Weinthal J, Frost JD, Briones G, Cairo MS. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia. J Clin Oncol 1994; 12:136-40.
28. 28. Olsen SL, Renlund DG, O'Connell JB, et al. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim-sulfamethoxazole. Transplantation 1993; 56:359-62.
29. 29. Kramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation - how effective and for how long? Transplantation 1992; 53:586-9.
30. 30. Gordon SM, LaRosa SP, Kalmadi S, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999; 28:240-6.
31. 31. Grossi P, Ippolitto GB, Goggi C, Cremaschi P, Scaglia M, Minoli L. Pneumocystis carinii pneumonia in heart transplant recipients. Infection 1993; 21:75-9.